NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

47 hedge funds and large institutions have $9.59M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

95% less call options, than puts

Call options by funds: $50K | Put options by funds: $1.06M

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$50K
Puts
$1.06M
Net Calls
Net Calls Change

Top Buyers

1
+$1.03M
2
+$402K
3
+$301K
4
Citadel Advisors
Citadel Advisors
Florida
+$111K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$106K

Top Sellers

1
-$4.46M
2
-$1.34M
3
-$1.01M
4
Northern Trust
Northern Trust
Illinois
-$457K
5
SM
Sabby Management
Florida
-$226K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$66K
27
$66K
28
$66K
29
$60K
30
$55K
31
$55K
32
$48K
33
$45K
34
$45K
35
$32K
36
$29K
37
$28K
38
$22K
39
$19K
40
$17K
41
$14K
42
$14K
43
$12K
44
$6K
45
$5K
46
$4K
47
$2K
48
–
49
–
50
–
1
2
3